Dataset Overview

The dataset provides a comprehensive look at HIV/AIDS adult prevalence rates, the number of people living with HIV, and annual deaths across different countries. It is based on publicly available data sources such as the CIA World Factbook, UNAIDS AIDS Info, and other global health organizations. The dataset primarily focuses on adult HIV prevalence (ages 15–49) and includes estimates from recent years (e.g., 2023–2024).

Data Science Applications

This dataset can be used for: - Epidemiological Analysis: Understanding the regional distribution of HIV/AIDS and identifying high-prevalence areas. - Predictive Modeling: Developing machine learning models to predict HIV prevalence trends or identify risk factors. - Resource Allocation: Informing policymakers about regions requiring urgent intervention or resource allocation. - Health Outcome Monitoring: Tracking progress in combating HIV/AIDS over time. - Social Determinants Research: Analyzing the relationship between socio-economic factors and HIV prevalence.

Column Descriptors

1. Country/Region: The geographical area being analyzed.
2. Adult Prevalence (%): Percentage of adults aged 15–49 living with HIV.
3. Number of People with HIV/AIDS: Absolute count of individuals living with HIV in the region.
4. Annual Deaths from HIV/AIDS: Number of deaths attributed to HIV/AIDS annually.
5. Year of Estimate: The year when the data was collected or estimated.

Ethically Mined Data

The dataset is ethically sourced from publicly available and credible platforms such as the CIA World Factbook, UNAIDS, and WHO. These organizations ensure transparency and ethical standards in data collection, protecting individual privacy while providing aggregate statistics for research purposes.

Acknowledgments

1. Data Source Platforms:
   • CIA World Factbook
   • UNAIDS AIDS Info
   • WHO Global Health Observatory
2. Dataset Visualization Image:
   • Created using DALL-E 3 for illustrative purposes.
3. Research Support:
   • Contributions from platforms like ResearchGate, NIMH, and others for insights into data science applications in HIV research.

This dataset serves as a valuable tool for researchers, policymakers, and public health professionals in addressing the global challenge of HIV/AIDS.

This statistic describes some of the key figures on the global HIV/AIDS epidemic as of 2024. For 2024, it was estimated that there were a total of 40.8 million people living with HIV/AIDS around the world. Around 31.6 million of these people had access to antiretroviral therapy treatment.

Among all countries worldwide those in sub-Saharan Africa have the highest rates of HIV. The countries with the highest rates of HIV include Eswatini, South Africa, and Lesotho. In 2024, Eswatini had the highest prevalence of HIV with a rate of around ** percent. Other countries, such as Zimbabwe, have significantly decreased their HIV prevalence. Community-based HIV services are considered crucial to the prevention and treatment of HIV. HIV Worldwide The human immunodeficiency virus (HIV) is a viral infection that is transmitted via exposure to infected semen, blood, vaginal and anal fluids, and breast milk. HIV destroys the human immune system, rendering the host unable to fight off secondary infections. Globally, the number of people living with HIV has generally increased over the past two decades. However, the number of HIV-related deaths has decreased significantly in recent years. Despite being a serious illness that affects millions of people, medication exists that effectively manages the progression of the virus in the body. These medications are called antiretroviral drugs. HIV Treatment Generally, global access to antiretroviral treatment has increased. However, despite being available worldwide, not all adults have access to antiretroviral drugs. There are many different antiretroviral drugs available on the market. As of 2024, ********, an antiretroviral marketed by Gilead, was the leading HIV treatment based on revenue.

Global HIV-AIDS Mortality by Country, 2023 Discover more data with ReportLinker!

UNAIDS estimated that there were some ******* people worldwide that died from acquired immune deficiency syndrome (AIDS) in 2024. This statistic depicts the total number of annual AIDS-related deaths worldwide from 2000 to 2024. HIV/AIDS burden A majority of countries with the highest burden due to HIV and AIDS are in Africa- in 2024, the highest number of AIDS-related deaths occurred in South Africa and Mozambique and the highest prevalence of HIV was found in Eswatini. Although access to life-saving antiretroviral therapy treatment (ART) has increased globally over recent years, many individuals living with HIV still lack access to ART. Barriers and interventions In part due to the development of ART, the number of people living with HIV worldwide is continuing to increase, reaching almost ** million in 2024. Important public health measures to combat the burden of the disease include a combination of biomedical and behavioral interventions such as pre- and post-exposure prophylaxis, and context-specific structural interventions to reduce barriers to supplies and education. One prominent barrier faced by those living with HIV is stigma, which can often cause disadvantages in many areas of life, including employment, use of health services, and social support.

This dataset provides estimates for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) spending for 188 countries for 2000 to 2015. Data is taken from the Institute for Health Metrics and Evaluation (IHME) and the Global Health Data Exchange.

Apportionment file 11480023 retrieved from OMB public records

The average for 2022 based on 135 countries was 1.66 percent. The highest value was in Swaziland: 25.9 percent and the lowest value was in Afghanistan: 0.1 percent. The indicator is available from 1990 to 2022. Below is a chart for all countries where data are available.

Introduction

• HIV (human immunodeficiency virus) is a virus that attacks the body's immune system. If HIV is not treated, it can lead to AIDS (acquired immunodeficiency syndrome) which currently has no cure. Once people get HIV, they have it for life. But with proper medical care, HIV can be controlled. Symptoms: Influenza-like illness; Fatigue… Treatments: Management of HIV/AIDS Type of infectious agent: Virus (Human Immunodeficiency Virus) • AIDS (acquired immune deficiency syndrome) is the name used to describe a number of potentially life-threatening infections and illnesses that happen when one’s immune system has been severely damaged by the HIV virus. While AIDS cannot be transmitted from 1 person to another, the HIV virus can.

Dataset

The data set contains data of the following:- 1. The top causes of deaths in the world 2. Total number of deaths due to HIV/AIDS 3. ART (Anti Retro-viral Therapy) coverage among people living with HIV 4. Knowledge among young citizens (15-24years) about HIV/AIDS 5. Population of HIV/AIDS patients living with TB and their death rate 6. Life expectancy rate among HIV/AIDS patients 7. HIV/AIDS Patients in different age groups 8. Women population living with HIV 9. Young women in India having the knowledge of HIV/AIDS 10. HIV/AIDS deaths in Indian states

Data was scrapped from the official website of UNICEF -https://data.unicef.org/ and https://data.gov.in/

Ask Phase

• Data gives the trend of increasing no. of HIV/AIDS patients across the world • The information available for each country is percentage of total Global AIDS patients • Time period traced is 2000-2019 • Key Questions to answer:  Which countries and regions are affected the most?  How are the different age groups affected?  How much is the ART (Anti Retro-viral Therapy) coverage among the patients and what is the life expectancy rate?  What percentage of the population is aware of the prevention and causes of HIV/AIDS

Prepare phase.

• By tabulating and filtering the data the required data was obtained to bring out observations. • Data was formatted to the desired format to perform further calculations. • Sorting of data region wise. • Columns with inconsistent and empty cells were deleted. • The data of India was extracted for further analysis • Duplicate entries and undesired data was removed

Process phase

For cleaning the dataset for further analysis MS Excel was used due to small data. • Used sumifs() functions to aggregate the data region wise • Used sumif() to segregate the no. of patients within different age groups • Used sumifs() to find the total number of TB patients among HIV deaths. • Used countif() to find the percentage of male and female patients. • Sorted data to find the top and bottom nation with most and least HIV/AIDS patients

Analyze phase

• Formed the following pivot tables to answer key target questions  Year v/s number of death rates  Country v/s death numbers to bring out nation wise deaths  Causes of death v/s the number of deaths to bring at which position AIDS causes causality  Year v/s percentage of life expectancy to observe the pattern of no. of survivors

Visualization phase

The data was visualized using Tableau.

Presentaion

The final presentation was prepared by accumulating all observations and inferences which is linked below https://docs.google.com/presentation/d/1NEX10Vz5u5Va3CrTLVbvsUHZjO-fn8EOeiOHkP03T3Q/edit?usp=sharing

In January 2025, President Trump ordered a pause on funding for the U.S. Agency for International Development (USAID) and a 90-day review of all U.S. foreign assistance. By the end of March, the review had been completed, 83 percent of USAID programs were terminated, and it was announced that certain USAID functions would be overtaken by the Department of State while all others would be discontinued. A preprint research paper posted in April 2025 looked at the possible effects that reductions or cessation of U.S. foreign aid would have on global health. The researchers estimated that the elimination of U.S. foreign aid for global health would result in an additional 15.2 million AIDS-related deaths from 2025 to 2040. Furthermore, they estimated that the loss of U.S. aid would lead to 26.2 million additional HIV infections over this period. This paper has not been peer-reviewed so the estimates should be interpreted with caution, but there is no doubt that such cuts to U.S. foreign aid will result in an increase in HIV infections and deaths, especially in high-impact countries. Trump has said that the United States spends too much on foreign aid and accused USAID of being corrupt and a waste of money. However, foreign aid accounts for just one percent of the federal budget. Furthermore, it is predicted that millions of people will die due to the dissolution of USAID, as vulnerable people around the world will no longer be able to access prevention and treatment for diseases such as HIV/AIDS, tuberculosis, and malaria.

Global HIV/AIDs initiative account, Iteration 1, Fiscal year 2026

BackgroundSince the first HIV/AIDS case appeared in 1980s, HIV/AIDS has been the focus of international attention. As a major public health problem, there are epidemiological uncertainties about the future of HIV/AIDS. It is important to monitor the global statistics of HIV/AIDS prevalence, deaths, disability adjusted life years (DALYs), and risk factors for adequate prevention and control.MethodsThe Global Burden of Disease Study 2019 database was used to analyze the burden of HIV/AIDS in 1990–2019. By extracting global, regional, and national data on HIV/AIDS prevalence, deaths, and DALYs, we described the distribution by age and sex, explored the risk factors, and analyzed the trends in HIV/AIDS.ResultsIn 2019, there were 36.85 million HIV/AIDS cases (95% UI: 35.15–38.86 million), 863.84 thousand deaths (95% UI: 78.61–99.60 thousand), and 47.63 million (95% UI: 42.63–55.65 million) DALYs. The global age-standardized HIV/AIDS prevalence, death, and DALY rates were 454.32 (95% UI: 433.76–478.59), 10.72 (95% UI: 9.70–12.39), and 601.49 (95% UI: 536.16–703.92) per 100,000 cases, respectively. In 2019, the global age-standardized HIV/AIDS prevalence, death, and DALY rates increased by 307.26 (95% UI: 304.45–312.63), 4.34 (95% UI: 3.78–4.90), and 221.91 (95% UI: 204.36–239.47) per 100,000 cases, respectively, compared to 1990. Age-standardized prevalence, death, and DALY rates decreased in high sociodemographic index (SDI) areas. High age-standardized rates were observed in low sociodemographic index areas, while low age-standardized rates were observed in high sociodemographic index areas. In 2019, the high age-standardized prevalence, death, and DALY rates were predominant in Southern Sub-Saharan Africa, and global DALYs peaked in 2004 and subsequently decreased. The highest global HIV/AIDS DALYs were in the 40–44 age group. The main risk factors affecting HIV/AIDS DALY rates included behavioral risks, drug use, partner violence, and unsafe sex.ConclusionsHIV/AIDS disease burden and risk factors vary by region, sex, and age. As access to health care increases across countries and treatment for HIV/AIDS infection improves, the HIV/AIDS disease burden is concentrated in areas with low SDIs, particularly in South Africa. Regional differences should be fully considered to target optimal prevention strategies and treatment options based on risk factors.

Context

In the time of epidemics, what is the status of HIV AIDS across the world, where does each country stands, is it getting any better. The data set should be helpful to explore much more about above mentioned factors.

Content

The data set contains data on

1. No. of people living with HIV AIDS
2. No. of deaths due to HIV AIDS
3. No. of cases among adults (19-45)
4. Prevention of mother-to-child transmission estimates
5. ART (Anti Retro-viral Therapy) coverage among people living with HIV estimates
6. ART (Anti Retro-viral Therapy) coverage among children estimates

Acknowledgements / Data Source

• WHO : https://www.who.int/hiv/data/en/
• UNESCO : https://data.unicef.org/resources/dataset/hiv-aids-statistical-tables/

Collection methodology

https://github.com/imdevskp/hiv_aids_who_unesco_data_cleaning

Cover Photo

Photo by Anna Shvets from Pexels https://www.pexels.com/photo/red-ribbon-on-white-surface-3900425/

Similar Datasets

• COVID-19 - https://www.kaggle.com/imdevskp/corona-virus-report
• MERS - https://www.kaggle.com/imdevskp/mers-outbreak-dataset-20122019
• Ebola Western Africa 2014 Outbreak - https://www.kaggle.com/imdevskp/ebola-outbreak-20142016-complete-dataset
• H1N1 | Swine Flu 2009 Pandemic Dataset - https://www.kaggle.com/imdevskp/h1n1-swine-flu-2009-pandemic-dataset
• SARS 2003 Pandemic - https://www.kaggle.com/imdevskp/sars-outbreak-2003-complete-dataset
• HIV AIDS - https://www.kaggle.com/imdevskp/hiv-aids-dataset

this graph was created in Tableu and Ourdataworld :

https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F16731800%2Fc5bb0b21c8b3a126eca89160e1d25d03%2Fgraph1.png?generation=1710708871099084&alt=media" alt="">

https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F16731800%2Ff81fcfa72e97f08202ba1cb06fe138da%2Fgraph2.png?generation=1710708877558039&alt=media" alt="">

https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F16731800%2Fabbdfd146844a7e8d19e277c2eecb83b%2Fgraph3.png?generation=1710708883608541&alt=media" alt="">

Understanding the Global Distribution of HIV/AIDS Deaths

Introduction:

HIV/AIDS remains one of the most significant public health challenges globally, with its impact varying widely across countries and regions. While the overall share of deaths attributed to HIV/AIDS stands at around 1.5% globally, this statistic belies the stark disparities observed on a country-by-country basis. This essay delves into the global distribution of deaths from HIV/AIDS, examining both the overarching trends and the localized impacts across different regions, particularly focusing on Southern Sub-Saharan Africa.

Understanding Global Trends:

At a global level, HIV/AIDS accounts for approximately 1.5% of all deaths. This figure, though relatively low in comparison to other causes of mortality, represents a significant burden on public health systems and communities worldwide. However, when zooming in on specific regions, such as Europe, the share of deaths attributable to HIV/AIDS drops significantly, often comprising less than 0.1% of total mortality. This pattern suggests varying levels of prevalence and effectiveness of HIV/AIDS prevention and treatment strategies across different parts of the world.

Regional Disparities:

The distribution of HIV/AIDS deaths is not uniform across the globe, with certain regions experiencing disproportionately high burdens. Southern Sub-Saharan Africa emerges as a focal point of the HIV/AIDS epidemic, with a significant portion of deaths attributed to the virus occurring in this region. Factors such as limited access to healthcare, socio-economic disparities, cultural stigmatization, and insufficient education about HIV/AIDS contribute to the heightened prevalence and impact of the disease in this area.

Southern Sub-Saharan Africa: A Hotspot for HIV/AIDS Deaths:

Within Southern Sub-Saharan Africa, countries such as South Africa, Botswana, and Swaziland stand out for their exceptionally high rates of HIV/AIDS-related mortality. In these nations, HIV/AIDS can account for up to a quarter of all deaths, highlighting the acute nature of the epidemic in these regions. The reasons behind this disproportionate burden are multifaceted, encompassing issues ranging from inadequate healthcare infrastructure to socio-cultural barriers inhibiting prevention and treatment efforts.

Challenges and Responses:

Addressing the unequal distribution of HIV/AIDS deaths necessitates a multi-faceted approach that encompasses both prevention and treatment strategies tailored to the specific needs of affected communities. Efforts to expand access to antiretroviral therapy (ART), promote comprehensive sexual education, combat stigma, and strengthen healthcare systems are crucial components of an effective response. Moreover, fostering partnerships between governments, civil society organizations, and international entities is essential for coordinating resources and expertise to tackle the HIV/AIDS epidemic comprehensively.

Lessons Learned and Future Directions:

The global distribution of deaths from HIV/AIDS underscores the importance of context-specific interventions that take into account the unique social, economic, and cultural factors influencing the spread and impact of the disease. While progress has been made in reducing HIV/AIDS-related mortality in some regions, much work remains to be done, particularly in areas where the burden of the epidemic remains disproportionately high. Going forward, sustained investment in research, healthcare infrastructure, and community empowerment initiatives will be vital for achieving meaningful reductions in HIV/AIDS deaths worldwide.

Conclusion:

In conclusion, the global distribution of deaths from HIV/AIDS reveals a complex landscape characterized by both overarching trends and localized disparities. While the overall share of deaths attributable to HIV/AIDS may seem relatively modest on a global scale, the stark contrasts observed across different countries and regions underscore the need for targeted interventions tailored to the specific contexts in which the epidemic is most pronounced. By addressing the underlying social, economic, and healthcare-related factors driving the unequal distribution of HIV/AIDS deaths, the global co...

In 2024, South Africa and Mozambique had the highest number of deaths due to AIDS worldwide, with around ** thousand and ** thousand such deaths, respectively. African countries account for eight of the top 10 countries with the highest number of AIDS-related deaths worldwide. AIDS-related deaths worldwide have been gradually declining over the past decade, decreasing from *** million deaths in 2010 to *** thousand deaths in 2024. HIV/AIDS HIV (human immunodeficiency virus) is an infectious sexually transmitted disease that is transmitted via exposure to infected semen, blood, vaginal and anal fluids and breast milk. HIV weakens the human immune system, resulting in the affected person being unable to fight off opportunistic infections. The top 15 countries worldwide with the highest prevalence of new HIV infections as of 2024 were all African. HIV treatment Although there is currently no effective cure for HIV, death can be prevented by taking HIV antiretroviral therapy (ART). Access to antiretroviral therapy worldwide has significantly increased in the past decade. As of 2024, around **** million people with HIV worldwide were receiving ART. The countries with the highest percentage of HIV-infected children who were receiving ART were Eswatini, Kenya, and Lesotho.

Source: https://en.wikipedia.org/wiki/HIV_adult_prevalence_rate This dataset provides detailed insights into the prevalence of HIV/AIDS among adults (ages 15–49) across various countries and regions 🌐. The data is primarily sourced from the CIA World Factbook and UNAIDS AIDS info platform, and reflects the most recent available estimates as of 2022–2024 📅.

📌 What's Included: Country/Region 🗺️ – The name of each nation or area.

Adult Prevalence of HIV/AIDS (%) 🔬 – The percentage of adults estimated to be living with HIV.

Number of People with HIV/AIDS 👥 – Estimated count of people infected in each country.

Annual Deaths from HIV/AIDS ⚰️ – Estimated number of HIV/AIDS-related deaths per year.

Year of Estimate 📆 – The year the data was reported or estimated.

📈 Key Highlights: Global Prevalence: Around 0.7% of the global population was living with HIV in 2022, affecting nearly 39 million people.

Hotspots: The epidemic is most severe in Southern Africa, with countries like Eswatini, Botswana, Lesotho, and Zimbabwe reporting adult prevalence rates above 20% 🔥.

High Burden Countries:

🇿🇦 South Africa: 17.3% prevalence, ~9.2 million infected.

🇹🇿 Tanzania: ~7.49 million.

🇲🇿 Mozambique: ~2.48 million.

🇳🇬 Nigeria: ~2.45 million (1.3% prevalence).

⚠️ Notes: Data may vary in accuracy and is subject to ongoing updates and verification 🔍.

Some entries include a dash ("-") where data was not published or available ❌.

Countries with over 1% adult prevalence are categorized under Generalized HIV Epidemics (GHEs) by UNAIDS 🚨.

📚 Data Sources: CIA World Factbook 🌐

UNAIDS AIDS Info 💉

Wikipedia 🧠 (used as a collection and compilation point, not primary source)

https://en.wikipedia.org/wiki/HIV_adult_prevalence_rate

The HIV/AIDS Diagnostics Market Report is Segmented by Product (Consumables, Instruments, Software & Services), Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Others), Technology (Immunoassay, Molecular Diagnostics, and More), End User (Hospitals, Diagnostic Laboratories, At-Home Settings, Others), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

This data set includes tables on persons living with HIV/AIDS, newly diagnosed HIV cases and all cause deaths in HIV/AIDS cases by gender, age, race/ethnicity and transmission category. In all tables, cases are reported as of December 31 of the given year, as reported by December 31, 2024, to allow a minimum of 12 months reporting delay. Gender is determined by both current gender and sex at birth variables; transgender values are assigned when current gender is identified as "Transgender" or when a discrepancy is identified between a person's sex at birth and their current gender (e.g., cases where sex at birth is "Male" and current gender is "Female" will become Transgender: Male to Female.) Prior to 2003, Asian and Native Hawaiian/Pacific Islanders were classified as one combined group. In order to present these race/ethnicities separately, living cases recorded under this combined classification were split and redistributed according to their expected proportional population representation estimated from post-2003 data.

The total number of people globally living with HIV has increased from **** million people in 2000 to **** million people in 2024. However, the total number of new HIV infections has decreased from *** million in 2000 to *** million in 2024. It has become easier for those infected with HIV to live longer lives. Death rates for HIV-positive people are decreasing, mostly due to antiretroviral drugs that have turned the infection into a chronic disease. Nevertheless, those with HIV are at a higher risk for conditions such as liver disease, heart disease, and cancer. Medication for HIV has become more widespread and has made HIV a more manageable condition. However, medicine is not widely accessible in the developing world, and treatment is still lacking. In Eswatini, around ** percent of all people between 15 and 49 years are living with HIV, while the percentage is around ** in South Africa. HIV infections are still especially widespread in Eastern and Southern Africa, with **** million people living with the condition in 2024. In the same year, there were around *** million people in Latin America living with HIV.